CATAPULT GROUP INTERNATIONAL LIMITED (CAT)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CAT - CATAPULT GROUP INTERNATIONAL LIMITED

FNArena Sector : Medical Equipment & Devices
Year End: March
GICS Industry Group : Technology Hardware & Equipment
Debt/EBITDA: 2.06
Index: ALL-ORDS

Catapult Group develops and sells wearable sensors to monitor and analyse athletic performance, including fitness and skill levels, injury risks and rehabilitation assistance. It listed on the ASX in 2014.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.79

02 Jul
2024

0.000

OPEN

$1.79

0.000

HIGH

$1.80

307,262

LOW

$1.78

TARGET
$1.75 -2.2% downside
OTHER COMPANIES IN THE SAME SECTOR
4DX . AT1 . BB1 . BRN . CBL . CGS . CMP . COH . CSX . CU6 . CYC . EBR . EMV . EYE . FPH . IDX . IME . IMR . IPD . LDX . MX1 . NAN . ONE . PCK . PEB . PGC . PME . RMD . SOM . TRJ . UBI . VTI .
FNARENA'S MARKET CONSENSUS FORECASTS
CAT: 1
Title FY25
Forecast		 FY26
Forecast
EPS (cps) - 13.9 xxx
DPS (cps) 0.0 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio N/A xxx
Dividend Yield 0.0% xxx
Div Pay Ratio(%) N/A xxx
This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192021202220232024
EPS Basic xxxxxxxxxxxxxxx-10.6
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx152.1 M
Book Value Per Share xxxxxxxxxxxxxxx48.3
Net Operating Cash Flow xxxxxxxxxxxxxxx45.4 M
Net Profit Margin xxxxxxxxxxxxxxx-16.68 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx-20.36 %
Return on Invested Capital xxxxxxxxxxxxxxx-16.77 %
Return on Assets xxxxxxxxxxxxxxx-10.23 %
Return on Equity xxxxxxxxxxxxxxx-20.36 %
Return on Total Capital xxxxxxxxxxxxxxx-15.10 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx29.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192021202220232024
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx27 M
Total Debt xxxxxxxxxxxxxxx28 M
Goodwill - Gross xxxxxxxxxxxxxxx79 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx18 M
Price To Book Value xxxxxxxxxxxxxxx3.21

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192021202220232024
Capex xxxxxxxxxxxxxxx41.1 M
Capex % of Sales xxxxxxxxxxxxxxx27.05 %
Cost of Goods Sold xxxxxxxxxxxxxxx148 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx27 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

31/05/2024

3

Hold

$1.75

-2.23%

According to Bell Potter, Catapult International reported mixed FY24 results. Revenue was better than expected and EBITDA was higher than forecast as gross profit came in above above estimates.

Free cash flow surprised to the upside highlights the broker at US$4.6m versus the analyst's forecast of US$1.6m, inferring the 2H24 was particularly robust.

Management offered no guidance, just some statements around the outlook, of which two were the same as FY24.

Bell Potter upgrades revenue forecasts for FY25 and FY26, while  EBITDA estimates have been downgraded due to higher share-based payments and purchase considerations.

Hold retained. Target price lifted to $1.75 from $1.50.

FORECAST
Bell Potter forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -13.88 cents.
Access Stockbroker Research History >

CAT STOCK CHART

FNArena News on CAT

1
FNArena Corporate Results Monitor – 07-06-2024

Jun 07 2024 - Australia
2
Australian Broker Call *Extra* Edition – Nov 22, 2023

Nov 22 2023 - Daily Market Reports
3
FNArena Corporate Results Monitor – 16-11-2023

Nov 16 2023 - Australia
4
Australian Broker Call *Extra* Edition – May 30, 2023

May 30 2023 - Daily Market Reports
5
FNArena Corporate Results Monitor – 29-05-2023

May 29 2023 - Australia

Latest Medical Equipment & Devices News

1
Dr Boreham’s Crucible: Blinklab

May 20 2024 - Small Caps
2
ResMed Silences The Doubters

Apr 29 2024 - Australia
3
Dr Boreham’s Crucible: 4D Medical

Apr 23 2024 - Small Caps
4
Uptrend Resumed For ResMed

Mar 19 2024 - Technicals
5
Dr Boreham’s Crucible: Cochlear

Feb 28 2024 - Australia
6
Rudi Interviewed: Ongoing Potential In Technology & Growth

Feb 19 2024 - Rudi's View
7
Dr Boreham’s Crucible: Artrya

Feb 15 2024 - Small Caps
8
ResMed Recovery Turns Into Hollywood Script

Jan 31 2024 - Australia
9
ResMed Makes A Comeback

Jan 29 2024 - Australia
10
ResMed: The Recovery Has Begun

Jan 23 2024 - Technicals